
David F Penson MD, MPH
Hamilton and Howd Chair in Urologic Oncology; Professor of Urologic Surgery and Medicine; Director, Center for Surgical Quality and Outcomes Research, Vanderbilt University Medical Center, Nashville, TNRecent Contributions to PracticeUpdate:
- Financial Margins for Prostate Cancer Surgery
- Variation and Predictors of Surgical Case Costs Among Urologists
- Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men
- Surgical Outcomes Monitoring Programs and Care Quality Measures
- Neoadjuvant Chemotherapy Cost-Effective in Muscle-Invasive Bladder Cancer
- Overdiagnosis and Overtreatment: Evaluation of What Physicians Tell Their Patients About Screening Harms
- Affordable Care Act—Changes Are Coming for Urologists, Ready or Not
- How Will the Affordable Care Act Affect Treatment of Urologic Cancers?
- Increased Subsequent Risk of Erectile Dysfunction in Patients With Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study
- High Risk for Other-Cause Mortality in Older Men With Prostate Cancer